Condition: Neoplasm, Colorectal · Cognitive Impairment · Cognitive Dysfunction · Sponsor: Joseph McCollom
The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.
This description comes directly from the study's public registry record.
Joseph McCollom, DO · 260-266-7100 · joseph.mccollom@parkview.com
Emily Powell, PHD · emily.powell@parkview.com
Always discuss trial participation with your own doctor first.
| Parkview Cancer Institute | Fort Wayne, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05014399